S 726
116th Congress
Senate
Health
Animal protection and human-animal relationships
Business records
Coal
Congressional oversight
Consumer affairs
Cosmetics and personal care
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Employee hiring
Federal preemption
Food and Drug Administration (FDA)
Government employee pay, benefits, personnel management
Government information and archives
Inflation and prices
Licensing and registrations
Manufacturing
Product safety and quality
Small business
State and local government operations
Personal Care Products Safety Act
Introduced: March 7, 2019
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 7, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1742)
Mar 7, 2019
Introduced in Senate
Plain-English summary
Personal Care Products Safety Act
This bill authorizes the Food and Drug Administration (FDA) to take various actions with respect to the regulation of cosmetics, such as collecting fees from manufacturers and distributors to fund cosmetics safety activities. The bill also authorizes the FDA to suspend the distribution of products that have a reasonable probability of causing serious adverse health consequences.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1742)
Committees of jurisdiction
1